Topics

Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic

2019-09-27 06:30:46 | BioPortfolio

Summary

This study will evaluate the feasibility and obtain a preliminary estimate of efficacy of feeding 15 g/day of a new novel prebiotic dietary fiber, termed polylactose, in 40 children (8-12 years old) with obesity (body mass index [BMI]-percentile >/= 95th) who have magnetic resonance imaging (MRI)-confirmed non-alcoholic fatty liver disease [NAFLD] (hepatic fat fraction >/= 5.5%), compared to a placebo of 15 g/d of cellulose, an inert dietary fiber.

Description

Approximately 13% of all children (2 - 19 years old) are afflicted with NAFLD with the prevalence of NAFLD increasing to 60-80% among youth with obesity. NAFLD is characterized by excessive deposition of fat in the liver, which is an independent risk factor for the development of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Unchecked, NAFLD can progress into more severe forms of liver disease, including NASH, cirrhosis, and hepatocellular carcinoma, which eventually can lead to liver transplantation or death. Unfortunately, treatment of NAFLD through lifestyle interventions is extremely challenging and minimally effective even under intensive conditions. Bariatric surgery has shown promise as a treatment approach in adults, but remains controversial for a treatment of NAFLD in pediatrics.Even if bariatric surgery is proven effective, the overall impact will be low since a very small proportion of adolescents with obesity opt for this extreme treatment. Moreover, surgery is not indicated in youth with milder forms of obesity or younger children and since NAFLD occurs across the entire age-spectrum and is not exclusive to youth with obesity, a large need would be unmet by surgical treatment options. Therefore, novel non-surgical approaches that complement lifestyle modification therapy are needed in order to advance the field in a meaningful way and to provide care to a wide-range of youth with NAFLD. However, no safe or effective pharmacotherapy treatment options are presently available for youth with NAFLD, leaving a tremendous gap in care. Therefore, altering the gut microbiome through administration of a prebiotic dietary fiber is an attractive treatment option.

To date, no medications have been successful at producing meaningful improvements in NAFLD among youth. Similarly, in adults, existing pharmacotherapy options elicit some improvement in liver enzymes and/or histology but have failed to demonstrate widespread efficacy. Moreover, most medications are not indicated for children under the age of 12, and pediatricians are adverse to using them until all other treatment options have failed. Therefore, alternative approaches must be taken in this difficult-to-treat clinical population to identify more effective treatment options. A prebiotic dietary fiber may offer a potential novel treatment option for NAFLD in children with obesity.

Subjects who are interested in participating in the study will be asked to come in for a screening visit where their parent will sign a parental consent form and the child will sign an assent form. Blood will be drawn for safety tests and biomarker sampling. Urine and stool will also be collected. A portable glucose monitor will be placed to collect timed glucose results. Subjects will have an MRI to confirm their NAFLD and their BMI will be calculated. Subjects will undergo a dual x-ray absorptiometry (iDXA) scan and lifestyle counseling. Subjects enrolled in this study will be randomly assigned (1:1) to receive either polylactose or the placebo. Subjects will take the polylactose or the placebo in foods provided by the study team (made in a food-grade space utilizing good manufacturing practices to minimize cross contamination). Subjects will take polylactose/placebo for 26 weeks. They will come have blood drawn for safety tests and biomarkers at weeks 8 and 26. They will have urine and stool samples collected at weeks 8, 20 and 26. Assessments of their glucose levels will be done via a wearable glucose monitor between the screening/randomization and week 4, and again between week 20 and week 26. MRI scans of the liver iDXA scans will be repeated at weeks 8 and 26. Lifestyle counseling and assessment of adverse events, compliance with taking the study product/placebo and tolerability of the intervention will take place at weeks 4, 8, 13, 20 and 26.

Study Design

Conditions

Obesity, Adolescent

Intervention

Polylactose, Placebo

Status

Not yet recruiting

Source

University of Minnesota - Clinical and Translational Science Institute

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-09-27T06:30:46-0400

Clinical Trials [1488 Associated Clinical Trials listed on BioPortfolio]

Interventions for Adolescent Obesity

This study will be the first to evaluate whether the short- and long-term use of activity tracking devices improve short- and long-term weight loss in adolescents. The investigators will b...

Evaluation of a Family-based Pediatric Obesity Program: TEENS+

Investigators propose to pilot an adolescent obesity intervention, TEENS+, to examine the feasibility of this dietary intervention strategy and preliminary effectiveness of two models of p...

SMART Use of Medication for the Treatment of Adolescent Severe Obesity

This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.

Ethnic Influences on Stress, Energy Balance and Obesity in Adolescents

The study will examine the mechanisms linking race, stress and biobehavioral factors to energy balance and obesity in both natural and controlled environments in African-American and Cauca...

Sex Steroids, Obesity and Lipids in Adolescent Females

To prospectively explore the relationships of endogenous sex steroid hormones and obesity and their interactions with lipoprotein cholesterol and apolipoprotein levels in nine and ten year...

PubMed Articles [4415 Associated PubMed Articles listed on BioPortfolio]

Cardiorespiratory Fitness as a Mediator of the Association between Physical Activity and Overweight and Obesity in Adolescent Girls.

Overweight and obesity (OW/OB) continue to be prominent health issues among adolescent girls. However, little is known about the interrelationships between physical activity (PA), cardiorespiratory fi...

Turkish Psychometric Properties of the Predictor Scales Affecting Adolescent Obesity.

Adolescent obesity is one of the most important public health problems today. Identifying factors that affect obesity in adolescents and developing programs to prevent obesity are very important. This...

Risky sexual behaviors and their association with overweight and obesity among adolescent students: a cross-sectional study.

To determine the prevalence of risky sexual behavior and its association with overweight and obesity among adolescent students.

Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity.

Background The beneficial effects of treating hypertriglyceridemic adults with omega-3 fatty acids have been reported. However, information regarding omega-3 treatment of pediatric patients is limited...

Marrow Adipose Tissue in Adolescent Girls with Obesity.

Marrow adipose tissue (MAT) is increasingly recognized as an active and dynamic endocrine organ that responds to changes in nutrition and environmental milieu. Compared to normal weight controls, adol...

Medical and Biotech [MESH] Definitions

Any observable response or action of an adolescent.

An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.

A condition of having excess fat in the abdomen. Abdominal obesity is typically defined as waist circumferences of 40 inches or more in men and 35 inches or more in women. Abdominal obesity raises the risk of developing disorders, such as diabetes, hypertension and METABOLIC SYNDROME X.

Adolescent hospitalized for short term care.

The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

More From BioPortfolio on "Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic"

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Searches Linking to this Trial